Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC
Clinical trial NCT04342910 · RECRUITING
Trial details
- NCT number
- NCT04342910
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-21
- Primary completion
- 2026-04-01
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.